NUTM1 and carcinoma: NC exhibits highly nonspecific morphological and clinical features overlapping with other carcinomas; as a result, it is not categorized through traditional methods such as site of origin or tissue of origin; instead, NC is diagnosed via NUT immunohistochemical staining using an antibody detecting NUT protein expression with 100% specificity and 87% sensitivity.